(19)
(11) EP 3 160 499 A1

(12)

(43) Date of publication:
03.05.2017 Bulletin 2017/18

(21) Application number: 15815785.9

(22) Date of filing: 29.06.2015
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
A61K 51/10(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/US2015/038252
(87) International publication number:
WO 2016/003869 (07.01.2016 Gazette 2016/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 30.06.2014 US 201462018989 P
15.12.2014 US 201462091932 P
26.02.2015 US 201514632480
16.04.2015 US 201562148428 P

(71) Applicant: Immunomedics, Inc.
Morris Plains, NJ 07950 (US)

(72) Inventors:
  • LIU, Donglin
    Morris Plains, NJ 07950 (US)
  • CHANG, Chien-Hsing
    Morris Plains, NJ 07950 (US)
  • GOLDENBERG, David M.
    Morris Plains, NJ 07950 (US)

(74) Representative: Bohmann, Armin K. 
Bohmann Anwaltssozietät Nymphenburger Straße 1
80335 München
80335 München (DE)

   


(54) ANTIBODIES REACTIVE WITH AN EPITOPE LOCATED IN THE N-TERMINAL REGION OF MUC5AC COMPRISING CYSTEINE-RICH SUBDOMAIN 2 (CYS2)